Rheumatology Therapeutics Industry Growth Expected to Reach $53.88 Billion by 2029 at a CAGR of 4.8% | Segmentation and Growth Opportunities
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the Rheumatology Therapeutics Market Growth Performance Trended Historically, And What Lies Ahead?_x000D_
In recent times, there has been a robust expansion in the size of the rheumatology therapeutics market. A growth from $42.4 billion in 2024 to $44.61 billion in 2025 is projected, maintaining a compound annual growth rate (CAGR) of 5.2%. Factors contributing to the growth during the historical period include an increase in the occurrence of rheumatologic disorders, a surge in the global aging population, heightened awareness of available treatment options, advancements in biological therapy, and widening access to healthcare in burgeoning markets._x000D_
_x000D_
#What Is the Forecast for the Rheumatology Therapeutics Market Size Through 2029?#_x000D_
The market size for rheumatology therapeutics is projected to experience consistent expansion in the coming years, reaching an estimated value of $53.88 billion in 2029 at a CAGR of 4.8%. The growth predicted for this period is associated with the transition to personalized medicine, increased implementation of biosimilars in rheumatology, amplified investment in R&D, the incorporation of digital health technology, and the regulatory approval of new therapies. During the forecast period, significant trends include the increasing use of telemedicine and remote monitoring, the introduction of targeted treatments for specific rheumatic ailments, a focus on patient-oriented care models, broadening the use of biologic treatments beyond monoclonal antibodies, and the application of value-based pricing models._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp_x000D_
_x000D_
#What are the Key Market Players in Rheumatology Therapeutics Market and How They’re Evolving?#_x000D_
Major companies operating in the rheumatology therapeutics market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Janssen Biotech, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals, UCB S.A., Galapagos NV (GLPG), Genentech Inc._x000D_
_x000D_
#What Are the Primary Growth Drivers in the Rheumatology Therapeutics Market?#_x000D_
The escalating occurrence of autoimmune disorders is predicted to drive the expansion of the rheumatology therapeutics market. Autoimmune diseases are conditions where the body’s immune system mistakenly launches an attack on its own tissues. The surging incidence of these disorders is attributed to a blend of genetic, environmental, and lifestyle factors, in addition to heightened awareness and enhanced diagnosis abilities. Autoimmune conditions necessitate rheumatology therapeutics to handle inflammation, ease symptoms, and thwart damage to joints and tissues resulting from the body’s immune system assault. For instance, in June 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, estimated that around 514,000 Australians, or 2.0% of the population, lived with rheumatoid arthritis in 2022. In 2023, rheumatoid arthritis accounted for 2.0% of total disease burden and 16% of all musculoskeletal condition burdens. Hence, the escalating occurrence of autoimmune diseases fuels the growth of the rheumatology therapeutics market._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=17246&type=smp_x000D_
_x000D_
#What Are the Leading Segments in the Global Rheumatology Therapeutics Industry?#_x000D_
The rheumatology therapeutics market covered in this report is segmented –_x000D_
_x000D_
1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes_x000D_
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy_x000D_
3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications_x000D_
_x000D_
Subsegments:_x000D_
1) By Disease Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs_x000D_
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): COX-2 Inhibitors, Traditional NSAIDs_x000D_
3) By Corticosteroids: Oral Corticosteroids, Injectable Corticosteroids, Topical Corticosteroids_x000D_
4) By Uric Acid Drugs: Uric Acid Lowering Agents, Uricosuric Agents, Pegloticase_x000D_
5) By Other Drug Classes: Immunosuppressants, Biologic Therapies, Analgesics_x000D_
_x000D_
#What Are the Key Market Trends in the Rheumatology Therapeutics Industry?#_x000D_
Major players in the rheumatology therapeutics market are creating novel solutions like intravenous (IV) formulations to improve treatment effectiveness and patient convenience. IV formulations are medicines or substances directly introduced into a vein via a needle or catheter. For example, the US Food and Drug administration (FDA) gave its approval to Cosentyx, an IV formulation developed by Novartis AG, a pharmaceutical firm based in Switzerland in October 2023. This unique version of Cosentyx is designed for treating adults suffering from psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). It functions by particularly targeting and impeding interleukin-17A (IL-17A), making it the sole non-tumor necrosis factor alpha (TNF-a) IV treatment for these diseases._x000D_
_x000D_
#Access The Full Report Here:#_x000D_
_x000D_
#What Is the Regional Outlook for the Rheumatology Therapeutics Market?#_x000D_
North America was the largest region in the rheumatology therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rheumatology therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Purchase The Full Report Today:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17246_x000D_
_x000D_
#This Report Delivers Insight On: #_x000D_
1. How big is the rheumatology therapeutics market, and how is it changing globally?_x000D_
2. Who are the major companies in the rheumatology therapeutics market, and how are they performing?_x000D_
3. What are the key opportunities and risks in the rheumatology therapeutics market right now?_x000D_
4. Which products or customer segments are growing the most in the rheumatology therapeutics market?_x000D_
5. What factors are helping or slowing down the growth of the rheumatology therapeutics market?_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 2071930708_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
